CClinicalTrials.gg
RecruitingNCT07490171Updated Aug 4, 2026

Traumatic Cardiac Arrest

An observational study in Trauma, sponsored by Methodist Health System. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-04.

Sponsored by Methodist Health System · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

This retrospective data repository will serve as a means to aggregate and analyze order of pre-hospital care (intubation, medication, etc) as it relates to Traumatic cardiac arrest.

Read the detailed description

The primary objective of this study is to establish a data repository that will be permissive of quality improvement studies/observations specific to patients with Traumatic cardiac arrest and evaluate impact of sequence of pre-hospital care in survival outcomes.

02

Conditions studied

  • Trauma

Browse trials for

03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients with traumatic cardiac arrest(TCA) have poor chances at survival despite rapid trauma activation responses. The traditional rescue sequence, focusing on airway, breathing, and circulation(ABC), has become standard of care for initial resuscitation for both trauma and non-trauma patients.

Inclusion criteria

≥18 years old Included in the MDMC Trauma Registry Cardiac arrest in pre-hospital setting or trauma bay

Exclusion criteria

Exclusion Criteria:

\<18 years old Prisoners, pregnant persons, or other protected population

04

Study design

Observational model
Other
Time perspective
Other
Enrollment
100 participants (estimated)
Target follow-up
5 Years
Patient registry
Yes

Groups and cohorts

  • Total Number and Description of Study Sites/Total Number of Subjects Projected

    This study will include all trauma patients who meet registry inclusion and arrive at the Methodist Dallas Medical Center(MDMC) trauma bay with Traumatic cardiac arrest. Enrollment will terminate once 5 years of data are captured: January 2018 through December 2023.

    Other: Medical/Phenotype Data Collection Procedures & Data to be Collected

Interventions

  • OtherMedical/Phenotype Data Collection Procedures & Data to be Collected

    The MDMC Trauma Registry will be queried for demographic information, diagnosis codes, admission dates, traumatic injury characteristics, surgical procedures, comorbidities, inpatient outcomes, complications, consultations, discharge location, and mortality. Additional laboratory values will be abstracted from Epic through retrospective chart review.

05

What researchers measure

Primary outcomes

  1. Total Number of Study Sites

    This study will include all trauma patients who meet registry inclusion and arrive at the Methodist Dallas Medical Center (MDMC) trauma bay with Traumatic cardiac arrest.

    Time frame: 5 years

06

Study locations

1 of 1 sites recruiting
  • Methodist Dallas Medical Center- Clinical Research Institute
    Dallas, Texas 75203, United States
    Recruiting
07

References and documents

Individual participant data

Plan to share: Yes — All information will be blinded in compliance with Good Clinical Practice.The investigator will make all possible efforts to ensure compliance with all policies regarding sharing of Protected Health Information or research information. Only de-identified Protected Health Information will be shared in relevant research mediums.

Supporting information: Study protocol

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07490171
Lead sponsor
Methodist Health System
Responsible party
Sponsor
First posted
Mar 24, 2026
Start date
Jan 30, 2024
Primary completion
Feb 2027 (estimated)
Completion
Feb 2028 (estimated)
Last update
Aug 4, 2026

Study contacts

Crystee Cooper, DHEd
Contact
ClinicalResearch@mhd.com
214-947-1280
Kavya Mankulangara
Contact
ClinicalResearch@mhd.com
214-947-4604
Andrew Karpisek, MD
principal investigator · Methodist Health System

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion